March 13, 2026Open Access
Comments on “Low-dose aspirin for preventing intrauterine growth restriction and pre-eclampsia in sickle cell pregnancy in Nigeria (PIPSICKLE): a randomised controlled trial”
Key Points
- This research aims to evaluate the effectiveness of low-dose aspirin in preventing intrauterine growth restriction and pre-eclampsia in pregnant individuals with sickle cell disease.
- Conducted a randomised controlled trial.
- Administered low-dose aspirin to a selected group.
- Monitored outcomes related to intrauterine growth and pre-eclampsia.
- Demonstrated a reduction in instances of intrauterine growth restriction.
- Showed a decrease in pre-eclampsia rates among participants.
- Highlighted positive outcomes for both maternal and fetal health.
Abstract
In the early 1970s, aspirin (acetylsalicylic acid) was shown to inhibit platelet aggregation by irreversibly acetylating platelet cyclooxygenase (COX), thereby suppressing the synthesis of its pro-aggregating product thromboxane A₂ (TxA₂)...